Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRNB

Principia Biopharma (PRNB) Stock Price, News & Analysis

Principia Biopharma logo

About Principia Biopharma Stock (NASDAQ:PRNB)

Advanced Chart

Key Stats

Today's Range
$100.05
$100.05
50-Day Range
$99.95
$100.27
52-Week Range
$25.35
$101.89
Volume
N/A
Average Volume
729,676 shs
Market Capitalization
$3.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Principia Biopharma and its competitors with MarketBeat's FREE daily newsletter.

PRNB Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
Principia College names new president
See More Headlines

PRNB Stock Analysis - Frequently Asked Questions

Principia Biopharma Inc. (NASDAQ:PRNB) issued its earnings results on Thursday, August, 6th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.03) by $1.34. The business had revenue of $50 million for the quarter, compared to the consensus estimate of $50 million.

Principia Biopharma (PRNB) raised $75 million in an IPO on Friday, September 14th 2018. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. BofA Merrill Lynch, Leerink Partners and Wells Fargo Securities acted as the underwriters for the IPO and Baird was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Principia Biopharma investors own include Pfizer (PFE), Advanced Micro Devices (AMD), AbbVie (ABBV), Bristol Myers Squibb (BMY), Cisco Systems (CSCO), QUALCOMM (QCOM) and VBI Vaccines (VBIV).

Company Calendar

Last Earnings
8/06/2020
Today
8/25/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PRNB
CIK
N/A
Fax
N/A
Employees
65
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$53.79 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-23.08%
Return on Assets
-21.11%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
17.01
Quick Ratio
17.01

Sales & Book Value

Annual Sales
$35.16 million
Price / Sales
94.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.95 per share
Price / Book
9.14

Miscellaneous

Outstanding Shares
33,209,000
Free Float
N/A
Market Cap
$3.32 billion
Optionable
Not Optionable
Beta
0.86
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:PRNB) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners